Myopia control means

US10156737B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10156737-B2
Application numberUS-201715416674-A
CountryUS
Kind codeB2
Filing dateJan 26, 2017
Priority dateApr 18, 2008
Publication dateDec 18, 2018
Grant dateDec 18, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Sets, kits or stocks of anti-myopia lenses and methods for their use, that do not require a clinician to measure peripheral refractive error in the eyes of myopic patients. Lenses having peripheral powers or defocus set in accordance with central corrective power will cover almost all normal myopes not worse than −6D central refractive error. For example, a kit or set of lenses ( 50 , FIG. 15 ) can have multiple parts or sub-sets each with a compartmented container with lenses arranged according to increments of central corrective power. The lenses of the first part have four steps of peripheral power or defocus to provide therapeutic effect and, while the lenses of the second part also have four steps, the level of therapeutic effect is higher. Other examples of sets, kits and stocks, as well as examples of lenses themselves, are disclosed together with methods of use.

First claim

Opening claim text (preview).

The invention claimed is: 1. An ophthalmic device for reducing the progression of myopia of an eye, said device comprising: a predetermined central sphere power, wherein the central sphere power is defined by an amount of myopia of an eye; a predetermined peripheral power profile, said peripheral power profile effects a relative peripheral refraction of a corrected eye, the peripheral power profile defining a peripheral defocus; and wherein, said peripheral defocus is a differential between the central sphere power and the peripheral power along the peripheral power profile, wherein said peripheral defocus is a function of the central sphere power. 2. The ophthalmic device according to claim 1 , wherein the peripheral defocus is defined by the average amount of relative peripheral refraction in a population. 3. The ophthalmic device according to claim 1 , wherein the ophthalmic device is part of a series of ophthalmic devices comprising: an ophthalmic device having an average peripheral defocus, an ophthalmic device having an above average peripheral defocus and an ophthalmic device having a below average peripheral defocus; said average peripheral defocus is determined by a mean from a defined population. 4. The ophthalmic device according to claim 1 , wherein the peripheral defocus is approximately first order linear as a constant function of the central sphere power. 5. The ophthalmic device according to claim 1 , wherein the peripheral defocus is non-linear as a function of the central sphere power. 6. The ophthalmic device according to claim 5 , wherein the peripheral defocus increases non-linearly or decreases non-linearly as a function of the central sphere power. 7. The ophthalmic device according to claim 1 , wherein the peripheral defocus up to 30 degrees from the central axis is approximately between 0.25D and 4.00D. 8. The ophthalmic device according to claim 1 , wherein the peripheral defocus up to 40 degrees from the central axis is approximately between 0.5D and 6.00D. 9. An ophthalmic device for reducing the progression of myopia of an eye, said device comprising: a predetermined central sphero-cylindrical power, wherein the central sphero-cylindrical power is defined by an amount of myopia of an eye; a predetermined peripheral power profile, wherein the peripheral power profile effects a relative peripheral refraction of a corrected eye; and a peripheral defocus of the peripheral power profile; wherein said peripheral defocus is a differential between the central power and the peripheral power along the peripheral power profile, and wherein said peripheral defocus is a function of the central power. 10. A method for reducing the progression of myopia of an eye, said method comprising: placing an ophthalmic device on an eye, said device comprising: a predetermined central sphere power, wherein the central sphere power is defined by an amount of myopia of an eye; a predetermined peripheral power profile, wherein the peripheral power profile effects a myopic defocus; and a peripheral defocus of the peripheral power profile; wherein said peripheral defocus is a differential between the central sphere power and a peripheral power value along the peripheral power profile, and wherein said peripheral defocus is a function of the central sphere power. 11. The method according to claim 10 , wherein the ophthalmic device is part of a series comprising: an ophthalmic device having an average peripheral defocus, an ophthalmic device having an above average peripheral defocus, and an ophthalmic device having a below average peripheral defocus; and wherein said average peripheral defocus is determined by a defined population. 12. The method according to claim 10 , wherein the peripheral defocus is approximately first order linear as a constant function of the central sphere power. 13. The method according to claim 10 , wherein the peripheral defocus is non-linear as a function of the central sphere power. 14. The method according to claim 13 , wherein the peripheral defocus increases non-linearly or decreases non-linearly as a function of the central sphere power. 15. The method according to claim 10 , wherein the peripheral defocus up to 30 degrees from the central axis is approximately between 0.25D and 4.00D. 16. The method according to claim 10 , wherein the peripheral defocus up to 40 degrees from the central axis is approximately between 0.5D and 6.00D.

Assignees

Inventors

Classifications

  • Annular configuration, e.g. pupil tuned · CPC title

  • Series of lenses, lens blanks · CPC title

  • G02C7/04Primary

    Contact lenses for the eyes (disinfection or sterilisation of contact lenses A61L12/00) · CPC title

  • Lenses; Lens systems {; Methods of designing lenses} · CPC title

  • characterised by electronic signal processing, e.g. eye models · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10156737B2 cover?
Sets, kits or stocks of anti-myopia lenses and methods for their use, that do not require a clinician to measure peripheral refractive error in the eyes of myopic patients. Lenses having peripheral powers or defocus set in accordance with central corrective power will cover almost all normal myopes not worse than −6D central refractive error. For example, a kit or set of lenses ( 50 , FIG. 15 …
Who is the assignee on this patent?
Novartis Ag, Holden Brien Vision Inst
What technology area does this patent fall under?
Primary CPC classification G02C7/04. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).